Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Topotecan/Cisplatin vs Etoposide/Cisplatin in Extensive-Stage SCLC
NCT00041015Phase 3Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Sep 2001
- Primary completion
- Nov 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of topotecan in small cell lung cancer (SCLC), sponsored by Case Comprehensive Cancer Center. Started Sep 2001; status: completed.
02
Drugs
topotecan
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00041015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00041015.